创新需要我们所有的人

Niels Emmerich, Vice President, Global Head Search & Evaluation
\r\nDebra Chao, Senior Director, Oncology
\r\nMurali Gopalakrishnan, Senior Director, Neuroscience
\r\nLiz Kowaluk, Senior Director, Specialty
\r\nArpita Maiti, Senior Director, Immunology
\r\nDouglas Faunce, Executive Director, Eye Care
\r\nChinmay Kanuga, Director, Allergan Aesthetics
\r\nJoachim Vogt, Director, Western Europe
\r\nSergio Capancioni, Director, Western Europe
\r\nWendy Tai, Director, Japan/Asia/Pacific

\r\n"}}" id="text-da680b2730" class="cmp-text">

全球主管副总裁尼尔斯·艾默里奇搜索和评估
高级主管黛布拉曹国伟,肿瘤
Murali Gopalakrishnan)高级主管,神经科学
莉斯Kowaluk、高级主管、专业
Arpita Maiti、高级主管、免疫学
执行董事Douglas Faunce,眼部护理
Chinmay Kanuga、导演、爱力根美学
约阿希姆沃格特、导演、西欧
塞吉奥Capancioni、导演、西欧
主任温迪Tai,日本/亚洲/太平洋

Jay Stamatis, Vice President, Head Business Development & Acquisitions
\r\nRahul Jerath, Senior Director, Oncology
\r\nTony Brazda, Senior Director, Allergan Aesthetics
\r\nRachel Strick, Senior Director, Immunology
\r\nDavid Moss, Associate VP, Eye Care, Neuropsych, Migraine
\r\nJohn FitzGerald, Senior Director, Outlicensing, Specialty
\r\nSridhar Mandapati, Head International Business Development

\r\n"}}" id="text-afee7ce55d" class="cmp-text">

主管副总裁杰伊Stamatis业务发展和收购狗万正网地址
拉胡尔Jerath、高级主管、肿瘤
高级主管托尼•Brazda爱力根美学
瑞秋击球、高级主管、免疫学
副总裁大卫•莫斯眼部护理,神经,偏头痛
高级主管约翰•菲茨杰拉德Outlicensing,专业
负责人bloom Mandapati国际业务发展狗万正网地址

Anna Maroney, Vice President, Global Alliances
\r\nJohn Larson, Senior Director Global Alliance Leader, Oncology, Marketed Drugs
\r\nJason Powell, Senior Director Global Alliance Leader, Oncology, Immunology
\r\nJon Kern, Senior Director Global Alliance Leader, Allergan Aesthetics, Immunology
\r\nShankar Subramanian, Senior Director Global Alliance Leader, Academic Collaborations
\r\nMelanie Patterson, Director Global Alliance Leader, Neuroscience, Oncology
\r\nAmanda McAllister, Director Global Alliance Leader, Specialty, Immunology, Oncology 
\r\nChing-Yi Wan, Associate Director Global Alliance Leader, Oncology
\r\nRajiv Janjikhel, Executive Director Global Alliance Leader, Eye Care, Neuroscience
\r\nCardine Nokwe, Director Global Alliance Leader, Specialty, Immunology

\r\n"}}" id="text-7e128adc4d" class="cmp-text">

安娜·克副总裁,全球联盟
全球联盟领袖高级主管约翰•拉森肿瘤学、销售药品
杰森·鲍威尔,高级主管全球联盟领袖,肿瘤学、免疫学
高级主管Jon Kern全球联盟领袖,爱力根美学,免疫学
高级主管Shankar萨勃拉曼尼亚全球联盟领袖、学术合作
主管梅勒妮帕特森全球联盟领袖,神经科学,肿瘤
负责人阿曼达·麦卡利斯特全球联盟领袖,专业、免疫学、肿瘤学
Ching-Yi Wan,全球联盟领袖、副主任肿瘤学
全球联盟执行主任Rajiv Janjikhel领袖,眼部护理,神经科学
主任Cardine Nokwe全球联盟领袖专业免疫学

Christian Schubert, Cambridge area
\r\nMargarita Chavez, Chicago / San Francisco area
\r\nJohn Gustofson, Boston / Cambridge area
\r\nCharles Kunsch, Boston / Cambridge area
\r\nJasmina Marjanovic, Boston / Cambridge area
\r\nDanjuma Quarless, San Francisco area
\r\nAna Dossantos, Cambridge area

\r\n"}}" id="text-d6a731b621" class="cmp-text">

基督教舒伯特,剑桥地区
玛格丽塔查韦斯,芝加哥和旧金山地区
约翰•Gustofson波士顿/剑桥地区
查尔斯•Kunsch波士顿/剑桥地区
嘉斯米娜Marjanovic,波士顿/剑桥地区
Danjuma夸尔斯,旧金山地区
安娜Dossantos,剑桥地区

As leading experts in autoimmune diseases and therapies, AbbVie is focused on developing new medicines to address chronic progressive diseases in the field of immunology. Our programs focus on investigating both targeted oral therapies and biologics. Our areas of interest include:

\r\n

\r\n
• Gastroenterology (Crohn’s disease, ulcerative colitis)
\r\n
• Dermatology (psoriasis, atopic dermatitis, hidradentis suppurativa)
\r\n
• Rheumatology (RA, PsA, AS, GCA, PMR)
\r\n
• Innate immunity / interferon and TH2 mediated diseases (SLE, systemic sclerosis, Sjögren’s syndrome, DM, eosinophilic diseases)
\r\n
• Select fibrotic conditions (systemic sclerosis, IPF)
\r\n

\r\n"}}" id="text-ec0f922d39" class="cmp-text">

权威专家在自身免疫性疾病和疗法,AbbVie专注于开发新药物来解决慢性进行性疾病免疫学领域的。我们的程序集中调查目标口服治疗和生物制剂。我们感兴趣的领域包括:

• 胃肠病学(克罗恩病、溃疡性结肠炎)
• 位患化脓性皮肤病(牛皮癣、皮炎,hidradentis)
• 风湿病学(RA, PsA, GCA, PMR)
• 先天免疫/干扰素和TH2介导的疾病(系统性红斑狼疮,系统性硬化症、干燥综合征、DM、嗜酸性疾病)
• 选择纤维条件(系统性硬化症,IPF)

Our goal is to transform the way cancer is treated. AbbVie is committed to discovering and developing therapies that work against the processes that cancer cells need to survive. We are committed to achieving long-term control of hematologic malignancies, and investing to identify and advance promising therapies for solid tumors. Our areas of interest include:

\r\n

\r\n
• Novel and differentiated programs directed towards enhanced tumor cell targeting, oncogenic signaling pathways and immuno-oncology
\r\n
• Targeted biologics and next generation cell therapies
\r\n
• Novel approaches to small molecules, including technologies to address hard-to-drug  target classes
\r\n

\r\n"}}" id="text-f9f7cc6cc7" class="cmp-text">

我们的目标是改变了治疗癌症的方法。AbbVie致力于发现和发展疗法对癌细胞存活所需的过程。我们致力于实现长期控制血液恶性肿瘤,和投资提前识别和有前途的治疗实体肿瘤。我们感兴趣的领域包括:

• 小说和分化程序指向增强肿瘤细胞靶向、致癌信号通路和immuno-oncology
• 针对生物制剂和下一代细胞疗法
• 小分子的新途径,包括技术解决hard-to-drug目标类

Our commitment to preserving the personhood of those living with neurological and psychiatric disorders is unwavering. AbbVie Neuroscience portfolio consists of approved therapies and a robust pipeline in neurological and psychiatric disorders with high unmet need. Our areas of interest include:

\r\n

\r\n
• Disease modification approaches for neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease, and select diseases driven by shared biological pathways
\r\n
• Psychiatric diseases, including  bipolar disorder, bipolar depression, major depressive disorder, generalized anxiety disorder and schizophrenia
\r\n
• Symptomatic approaches with clinical validation for cognitive and neurobehavioral deficits in Alzheimer’s and Parkinson’s disease
\r\n
• Migraine
\r\n
• Spasticity and movement disorders; neurorestoration in multiple sclerosis
\r\n

\r\n"}}" id="text-d789c517b9" class="cmp-text">

我们致力于保护这些神经和精神疾病的人格是坚定的。AbbVie神经科学的投资组合包括批准在神经和精神疾病治疗和一个健壮的管道未满足的需求高。我们感兴趣的领域包括:

• 疾病的修改方法为神经退行性疾病,包括阿尔茨海默氏症和帕金森氏症,并选择疾病由共同的生物学途径
• 精神疾病,包括双相情感障碍,双相抑郁,重度抑郁症、广泛性焦虑障碍和精神分裂症
• 有症状的方法与临床验证认知和神经行为障碍在阿尔茨海默氏症和帕金森氏症
• 偏头痛
• 痉挛状态和运动障碍;neurorestoration在多发性硬化症

Our mission in eye care remains to protect and preserve vision for a better quality of life for the millions of people who experience vision loss every year. AbbVie continues to search for new therapeutics that address unmet needs and new approaches to retina-related diseases, glaucoma, dry eye disease, and refractive conditions. We are focused on both biologics and small molecules, as well as next generation drug delivery technologies. Our areas of interest include:

\r\n

\r\n
• Retinal degeneration, including Dry AMD/geographic atrophy, Wet AMD and diabetic retinal diseases
\r\n
• Dry eye and ocular surface disease of various etiologies
\r\n
• Glaucoma, addressing intraocular pressure control and neuroprotection
\r\n
• Refractive medicine, including presbyopia, myopia and corneal dystrophies
\r\n

\r\n"}}" id="text-e39f18e0d0" class="cmp-text">

眼部护理我们的使命仍在保护视力,为了更好的生活质量每年成千上万的人体验视力丧失。AbbVie继续寻找新的疗法,解决未满足的需求和新方法retina-related疾病、青光眼、干的眼疾病,和折射条件。我们专注于小分子和生物制剂,以及下一代药物输送技术。我们感兴趣的领域包括:

• 视网膜变性,包括干AMD /地理萎缩,湿性AMD和糖尿病视网膜疾病
• 干燥的眼睛和眼表面各种病因的疾病
• 青光眼,解决眼压控制和神经保护
• 屈光医学,包括远视、近视和角膜营养不良

Allergan Aesthetics is developing a portfolio of innovative products in the areas of facial and body filling, breast reconstruction/augmentation, and regenerative soft tissue repair. We are interested in strategic collaborations that broaden our understanding of the aging process, and therapeutic  targets to address the natural, physical, and biological changes that occur with age. We seek out and partner with strategic collaborators for neurotoxins, dermal fillers, body aesthetics, plastic surgery and regenerative medicine, hair growth, and skin care. We are also interested in exploring the use of energy-based devices for the field of body aesthetics. Cell and gene therapies with a focus on extracellular matrix components including collagen and elastin are also of interest. Our areas of interest include:

\r\n

\r\n
• Dermal injectables for skin and tissue
\r\n
• Plastics and regenerative medicine
\r\n
• Toxins for aesthetic and therapeutics
\r\n
• Hair growth
\r\n
• Body contouring and fat reduction
\r\n
• Topical skin care
\r\n

\r\n"}}" id="text-975dceb491" class="cmp-text">

爱力根美学发展的领域的创新产品组合的面部和身体,乳房重建/增加,再生软组织修复。我们感兴趣的是战略合作,扩大我们对衰老过程的理解,和治疗目标,解决自然、物理和生物随着年龄而发生的变化。我们寻找并与战略合作者合作神经毒素,真皮填充剂,身体美学,整形手术和再生医学,毛发生长,皮肤护理。我们也有兴趣探索能源设备的使用领域的身体美学。细胞和基因疗法与专注于细胞外基质组件包括胶原蛋白和弹性蛋白也感兴趣的。我们感兴趣的领域包括:

• 真皮注射剂对皮肤和组织
• 塑料和再生医学
• 毒素美容疗法
• 头发的生长
• 身体轮廓和脂肪减少
• 局部皮肤护理

We also selectively focus our attention on other areas where there is unmet need:

\r\n

\r\n
• Virology
\r\n
• Cystic fibrosis
\r\n
• Women’s health
\r\n
• Platforms and technologies
\r\n

\r\n"}}" id="text-df9e0a63d2" class="cmp-text">

我们也有选择地集中我们的注意力在其他地方有未满足的需求:

• 病毒学
• 囊性纤维化
• 妇女的健康
• 平台和技术